Cardiol Therapeutics Inc. Class A Common Shares
CRDL Real Time Price USDRecent trades of CRDL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CRDL's directors and management
Government lobbying spending instances
-
$40,000 Oct 16, 2022 Issue: None
-
$40,000 Jul 12, 2022 Issue: None
-
$40,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Jan 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Oct 07, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Jul 12, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Apr 15, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 18, 2021 Issue: Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CRDL in WallStreetBets Daily Discussion
Recent insights relating to CRDL
Recent picks made for CRDL stock on CNBC
ETFs with the largest estimated holdings in CRDL
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CRDL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.